Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1082543

registered interest
date	06/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he will take in the forthcoming workforce implementation plan to ensure that there are sufficient staff in the NHS to diagnose and treat cancer..
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	229138
answer	answer is ministerial correction date of answer 12/03/2019 answer text <p>Health Education England (HEE) published its first ever Cancer Workforce Plan in December 2017. HEE intended to publish a second phase, longer-term strategy that looked at the cancer workforce needs beyond 2021. This work was started and stakeholders from within the National Health Service and the charitable sector contributed to the early discussions. This work has since been superseded by publication of the NHS Long Term Plan in January 2019.</p><p> </p><p>My Rt. hon. Friend the Secretary of State for Health and Social Care has subsequently commissioned Baroness Dido Harding, working closely with Sir David Behan, to lead a number of programmes to engage with key NHS interests to develop a detailed workforce implementation plan. These programmes will consider detailed proposals to grow the workforce rapidly, including staff working on cancer, consider additional staff and skills required, build a supportive working culture in the NHS and ensure first rate leadership for NHS staff.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/03/2019 12:41:00 answering member 4067 label Biography information for Steve Brine
tabling member	3930 label Biography information for Caroline Lucas

1082557

registered interest
date	06/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the proportion of eligible adults who have received (a) abdominal aortic aneurysm, (b) bowel, (c) breast and (d) cervical screening in (i) Lambeth CCG (ii) Southwark CCG and (iii) England in each year since 2015.
tabling member constituency	Dulwich and West Norwood
tabling member printed	Helen Hayes
uin	229212
answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>Abdominal aortic aneurysm screening coverage for Lambeth Clinical Commissioning Group (CCG), Southwark CCG and England in each year since 2015/16 can be seen in the following table.</p><p> </p><p>Abdominal aortic aneurysm screening coverage for Lambeth CCG, Southwark CCG and England, 2015/16 to 2017/18.</p><table><tbody><tr><td><p> </p></td><td><p>2015/16 % (tested)</p></td><td><p>2016/17 % (tested)</p></td><td><p>2017/18 % (tested)</p></td></tr><tr><td><p>Lambeth CCG</p></td><td><p>61.0 (627)</p></td><td><p>67.5 (664)</p></td><td><p>53.3 (582)</p></td></tr><tr><td><p>Southwark CCG</p></td><td><p>58.8 (550)</p></td><td><p>73.4 (680)</p></td><td><p>45.9 (435)</p></td></tr><tr><td><p>England</p></td><td><p>79.9 (227,442)</p></td><td><p>81.1 (228,441)</p></td><td><p>80.8 (230,543)</p></td></tr></tbody></table><p>Notes:</p><ol><li>Sources:<a href="https://www.gov.uk/government/publications/abdominal-aortic-aneurysm-screening-2015-to-2016-data" target="_blank">https://www.gov.uk/government/publications/abdominal-aortic-aneurysm-screening-2015-to-2016-data</a></li></ol><p> </p><p><a href="https://www.gov.uk/government/publications/abdominal-aortic-aneurysm-screening-2016-to-2017-data" target="_blank">https://www.gov.uk/government/publications/abdominal-aortic-aneurysm-screening-2016-to-2017-data</a></p><p> </p><p><a href="https://www.gov.uk/government/publications/abdominal-aortic-aneurysm-screening-2017-to-2018-data" target="_blank">https://www.gov.uk/government/publications/abdominal-aortic-aneurysm-screening-2017-to-2018-data</a></p><p> </p><ol start="2"><li>Total number of people screened is provided in brackets.</li></ol><p> </p><ol start="3"><li>Coverage is the percentage of the eligible population that is successfully screened within the year plus three months:</li></ol><p> </p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/773136/NHS_AAA_screening_programme_standards_data_report_april_2017_to_march_2018.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/773136/NHS_AAA_screening_programme_standards_data_report_april_2017_to_march_2018.pdf</a></p><p> </p><p>Bowel cancer screening coverage for Lambeth CCG, Southwark CCG and England is attached. Coverage for bowel cancer screening is defined as the number of persons registered to a general practice who are screened adequately in the previous 30 months, which is the routine period in which bowel cancer screening takes place for an individual, divided by the number of eligible persons on the last day of the review period for this report data is taken in April 2015, 2016, 2017 and 2018. This captures the coverage for the eligible population over the standard period of time in which an individual should attend for a bowel cancer screening.</p><p> </p><p>Breast screening coverage for Lambeth CCG, Southwark CCG and England is attached. Coverage for breast screening is defined as the number of women registered to a general practice screened adequately in the previous 36 months, which is the routine period in which breast screening takes place for an individual, divided by the number of eligible women on last day of the review period for this report data is taken in April 2015, 2016, 2017 and 2018. This captures the coverage for the eligible population over the standard period of time in which a woman should attend for breast screening.</p><p> </p><p>Cervical screening coverage for Lambeth CCG, Southwark CCG and England is attached. Coverage for cervical screening is defined as the number of women screened adequately in the previous 42 months (if aged 24-49) or 66 months (if aged 50-64) divided by the number of eligible women on last day of review period for this report data is taken in April 2015, 2016, 2017 and 2018. This captures the coverage for the eligible population over the standard period of time in which a woman should attend for cervical screening.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/03/2019 18:30:38 answering member 4067 label Biography information for Steve Brine attachment 1 file name PQ229212 attached table.docx title PQ229212 attached table previous answer version 106920 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	4510 label Biography information for Helen Hayes

1082558

registered interest
date	06/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the National Audit Office report entitled Investigation into the management of Health Screening, published 1 February 2019, what steps his Department is taking to ensure NHS screening laboratories are sufficiently staffed.
tabling member constituency	Dulwich and West Norwood
tabling member printed	Helen Hayes
uin	229213
answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>The National Health Service Long Term Plan sets out specific workforce actions developed by NHS Improvement and others to have positive impact for workforces, including the screening and diagnostic workforce. NHS Improvement and the Department will discuss these actions when the education and training budget for Health Education England is set in 2019. This includes a proposal to recruit an additional 1,500 clinical and diagnostic staff across seven priority specialisms between 2018 and 2021.</p><p> </p><p>With specific reference to the national cervical screening programme that includes NHS laboratories, the replacement of liquid based cytology with human papillomavirus (HPV) testing as the primary screen, has had a significant impact on the ability to maintain staff in the cervical screening programme’s laboratory workforce. The HPV pilot evaluation suggested that the need for a cytology workforce could reduce by as much as 85% when HPV testing is introduced as the primary screen during 2019.</p><p> </p><p>NHS England is undertaking a national procurement process to secure providers of laboratory services to deliver HPV primary screening across England. The outcome of the process will be known by the end of April 2019, with national coverage in place by December 2019.</p><p> </p><p>To maintain the service and accommodate current staffing levels a majority of existing HPV pilot sites and some non-pilot sites have already converted more of their cervical screening activity to HPV primary screening, freeing up cytology capacity.</p><p> </p><p>In addition, Professor Sir Mike Richards is leading a major review of national cancer screening programme pathways as part of the NHS Long Term Plan’s renewed drive to improve care and save lives. Professor Richards’ review is due to report in summer 2019.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/03/2019 18:24:00 answering member 4067 label Biography information for Steve Brine previous answer version 106922 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	4510 label Biography information for Helen Hayes

1082564

registered interest
date	06/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Food: Labelling
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when the results of the consultation on mandating calorie labelling in the out-of-home sector will be published.
tabling member constituency	Hove
tabling member printed	Peter Kyle
uin	229218
answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>I refer the hon. Member to the answer I gave to the hon. Member for South West Bedfordshire (Andrew Selous MP) on 23 January 2019 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-01-21/210542/" target="_blank">210542</a>.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/03/2019 18:24:52 answering member 4067 label Biography information for Steve Brine previous answer version 106926 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	4505 label Biography information for Peter Kyle

1082570

registered interest
date	06/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Spinal Muscular Atrophy: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that (a) nusinersen/Spinraza and (b) other life-saving drugs are made available for people with spinal muscular atrophy.
tabling member constituency	Dudley North
tabling member printed	Ian Austin
uin	229106
answer	answer is ministerial correction date of answer 14/03/2019 answer text <p>The Government wants National Health Service patients to be able to benefit from effective new medicines in a way that represents value for money to the taxpayer. Through its technology appraisal and highly specialised technologies programmes, the National Institute for Health and Care Excellence (NICE) makes recommendations for the NHS on whether new medicines should be routinely funded by the NHS. NHS organisations are legally required to fund medicines recommended by NICE.</p><p> </p><p>NICE is currently developing technology appraisal guidance on the use of Spinraza for the treatment of spinal muscular atrophy. NICE was unable to recommend Spinraza as an effective use of NHS resources in its draft guidance published in August 2018. Discussions have since been taking place between the manufacturer of Spinraza, Biogen, and NHS England to explore whether there are commercial flexibilities that might enable NICE to recommend the drug as a clinically and cost-effective use of NHS resources. Biogen has now submitted a revised submission and a meeting of NICE’s independent Appraisal Committee took place on 6 March to consider the recommendations. Details from the meeting will made available on the NICE website in due course.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/03/2019 10:47:04 answering member 4067 label Biography information for Steve Brine
tabling member	1511 label Biography information for Lord Austin of Dudley

1082590

registered interest
date	06/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tobacco
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 February 2019 to Question 222001, when Public Health England plans to undertake an independent academic review of heated tobacco products.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	229155
answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>Under the Government’s Tobacco Control Plan for England, Public Health England (PHE) is committed to conducting an annual review of the evidence on e-cigarettes and other nicotine delivery systems until the end of the Parliament in 2022. This can be viewed at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/towards-a-smoke-free-generation-tobacco-control-plan-for-england" target="_blank">https://www.gov.uk/government/publications/towards-a-smoke-free-generation-tobacco-control-plan-for-england</a></p><p> </p><p>The scope of these reviews includes heated tobacco products and PHE published an evidence review of e-cigarettes and heated tobacco products in February 2018. The review is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/e-cigarettes-and-heated-tobacco-products-evidence-review" target="_blank">https://www.gov.uk/government/publications/e-cigarettes-and-heated-tobacco-products-evidence-review</a></p><p> </p><p>The Government currently has no plans to conduct a separate review of heated tobacco products outside of the programme.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/03/2019 18:31:49 answering member 4067 label Biography information for Steve Brine previous answer version 106923 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	1604 label Biography information for Mr Virendra Sharma

1082627

registered interest
date	06/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Physiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of physiotherapists that will be working in primary care in each of the next five years.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	229096
answer	answer is ministerial correction date of answer 15/03/2019 answer text <p>The NHS Long Term Plan made a clear commitment to the future of general practice, with primary and community care set to receive at least £4.5 billion more in real terms a year by 2023/24, meaning spending on these services will grow faster than the rising National Health Service budget. Since the launch of the Long Term Plan, NHS England and the British Medical Association’s General Practitioners (GP) Committee have agreed a five-year GP (General Medical Services) contract framework from 2019/20. The new contract framework will be essential to deliver the ambitions set out in the NHS Long Term Plan through strong general practice services.</p><p> </p><p>The contract included funding for the new Additional Roles Reimbursement Scheme, in Primary Care Networks (PCNs). PCNs will be guaranteed funding for an up to estimated 20,000 additional staff by 2023/24. This funds new roles for which there is both credible supply and demand. The scheme will meet a recurrent 70% of the costs of additional clinical pharmacists, physician associates, first contact physiotherapists, and first contact community paramedics; and 100% of the costs of additional social prescribing link workers.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 229699 question first answered 15/03/2019 13:30:56 answering member 4067 label Biography information for Steve Brine
tabling member	308 label Biography information for Mr Jim Cunningham

1082628

registered interest
date	06/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Physiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that people living with chronic pain receive support from physiotherapists to help them stay in employment.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	229097
answer	answer is ministerial correction date of answer 15/03/2019 answer text <p>The routine assessment and management of pain is a required competency of all healthcare professionals. Many patients with chronic pain can be successfully supported and managed through routine primary and secondary care pain management services. Approaches to treatment are not all pharmacological; education in self-management techniques to aid symptom control may also be appropriate for some patients.</p><p> </p><p>As set out in the NHS Long Term Plan, published on 7 January 2019, NHS England will expand the number of physiotherapists working in primary care networks, enabling people to see the right professional first time, without needing a general practitioner referral. NHS England will also expand access to support such as the online version of ESCAPE-pain (Enabling Self-management and Coping with Arthritic Pain through Exercise), a digital version of the well-established, face-to-face group programme.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/03/2019 13:36:01 answering member 4067 label Biography information for Steve Brine
tabling member	308 label Biography information for Mr Jim Cunningham

1082652

registered interest
date	06/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the ability of medium-sized companies to pay the proposed charges for continuing to submit technology appraisals and highly specialised technology recommendations.
tabling member constituency	Bolton West
tabling member printed	Chris Green
uin	229236
answer	answer is ministerial correction date of answer 15/03/2019 answer text <p>The Government consulted on the proposed introduction of charges for the development of the National Institute for Health and Care Excellence (NICE) technology appraisal and highly specialised technology recommendations and has taken full account of the comments received in the Government response which is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/consultations/nice-recommendations-charging-and-appeal-panels" target="_blank">https://www.gov.uk/government/consultations/nice-recommendations-charging-and-appeal-panels</a></p><p> </p><p>The Government states in the response that it is of the view that the proposed NICE charges are affordable for medium-sized companies, but that it will keep this position under review.</p><p> </p><p>As explained in the Government response and Impact Assessment, small companies whose products are undergoing assessment will benefit from a 75% discount, which is intended to minimise barriers to the participation of small companies.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 229238 question first answered 15/03/2019 12:25:38 answering member 4067 label Biography information for Steve Brine
tabling member	4398 label Biography information for Chris Green

1082654

registered interest
date	06/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what support his Department plans to provide to medium-sized companies who will not be eligible for the 75 per cent discount in relation to the proposed charges for making a technology appraisal and a highly specialised technology appraisal.
tabling member constituency	Bolton West
tabling member printed	Chris Green
uin	229238
answer	answer is ministerial correction date of answer 15/03/2019 answer text <p>The Government consulted on the proposed introduction of charges for the development of the National Institute for Health and Care Excellence (NICE) technology appraisal and highly specialised technology recommendations and has taken full account of the comments received in the Government response which is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/consultations/nice-recommendations-charging-and-appeal-panels" target="_blank">https://www.gov.uk/government/consultations/nice-recommendations-charging-and-appeal-panels</a></p><p> </p><p>The Government states in the response that it is of the view that the proposed NICE charges are affordable for medium-sized companies, but that it will keep this position under review.</p><p> </p><p>As explained in the Government response and Impact Assessment, small companies whose products are undergoing assessment will benefit from a 75% discount, which is intended to minimise barriers to the participation of small companies.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 229236 question first answered 15/03/2019 12:25:38 answering member 4067 label Biography information for Steve Brine
tabling member	4398 label Biography information for Chris Green